1 Min Read
June 8 (Reuters) - SENSORION SA:
* TAKES A KEY STEP TOWARDS PHASE 2 WITH THE SENS-401 POSITIVE RESULTS OBTAINED IN THE PHASE 1 CLINICAL TRIAL Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.